{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T09:54:48Z","timestamp":1777197288314,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bbr.2015.07.015","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T17:40:49Z","timestamp":1437414049000},"page":"166-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Interferon-alpha treatment induces depression-like behaviour accompanied by elevated hippocampal quinolinic acid levels in rats"],"prefix":"10.1016","volume":"293","author":[{"given":"Christina Weide","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Eskelund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Budac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Tillmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Liebenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betina","family":"Elfving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregers","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbr.2015.07.015_bib0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.4049\/jimmunol.177.4.2391","article-title":"Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO","volume":"177","author":"Basu","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbr.2015.07.015_bib0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system","volume":"22","author":"Bonaccorso","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2015.07.015_bib0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.bbr.2015.07.015_bib0020","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2015.07.015_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2010.10.009","article-title":"Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C","volume":"63","author":"Comai","year":"2011","journal-title":"Pharmacol. Res.: Off. J. Ital. Pharmacol. Soc."},{"issue":"5","key":"10.1016\/j.bbr.2015.07.015_bib0030","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.pnpbp.2005.03.008","article-title":"Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats","volume":"29","author":"De La Garza","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2015.07.015_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003495-199345020-00003","article-title":"Interferon-alpha in malignant and viral diseases. A review","volume":"45","author":"Dorr","year":"1993","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bbr.2015.07.015_bib0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/brbi.1993.1011","article-title":"Repeated injections of interferon-alpha A\/D in Balb\/c mice: behavioral effects","volume":"7","author":"Dunn","year":"1993","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2015.07.015_bib0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pbb.2014.09.014","article-title":"Lipopolysaccharide repeated challenge followed by chronic mild stress protocol introduces a combined model of depression in rats: reversibility by imipramine and pentoxifylline","volume":"126","author":"Elgarf","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.bbr.2015.07.015_bib0050","first-page":"466","article-title":"Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma","volume":"51","author":"Friebe","year":"2010","journal-title":"Psychosomatics"},{"issue":"9","key":"10.1016\/j.bbr.2015.07.015_bib0055","first-page":"873","article-title":"Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic\/psychiatric symptoms","volume":"3","author":"Fuchs","year":"1990","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"10.1016\/j.bbr.2015.07.015_bib0060","first-page":"196","article-title":"Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b","volume":"1","author":"Fuchs","year":"1992","journal-title":"Eur. J. Med."},{"issue":"1-3","key":"10.1016\/j.bbr.2015.07.015_bib0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.03.076","article-title":"Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain","volume":"612","author":"Guo","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbr.2015.07.015_bib0070","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"Kohler","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2015.07.015_bib0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbr.2010.11.027","article-title":"The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis","volume":"218","author":"Krass","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2015.07.015_bib0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10787-011-0112-6","article-title":"Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients","volume":"20","author":"Krause","year":"2012","journal-title":"Inflammopharmacology"},{"issue":"10","key":"10.1016\/j.bbr.2015.07.015_bib0085","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.psyneuen.2006.07.006","article-title":"Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis rats","volume":"31","author":"Loftis","year":"2006","journal-title":"Psychoneuroendocrinology"},{"issue":"6\u20137","key":"10.1016\/j.bbr.2015.07.015_bib0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2015.07.015_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00474-9","article-title":"Enhancement of immobility in mouse forced swimming test by treatment with human interferon","volume":"356","author":"Makino","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2015.07.015_bib0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s002130050031","article-title":"Human interferon-alpha increases immobility in the forced swimming test in rats","volume":"148","author":"Makino","year":"2000","journal-title":"Psychopharmacol. (Berl.)"},{"issue":"6","key":"10.1016\/j.bbr.2015.07.015_bib0105","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/jnc.12350","article-title":"Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease","volume":"127","author":"Mazarei","year":"2013","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.bbr.2015.07.015_bib0110","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/ajp.156.7.1120","article-title":"Depression from interferon therapy in patients with hepatitis C","volume":"156","author":"Miyaoka","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"13","key":"10.1016\/j.bbr.2015.07.015_bib0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbr.2015.07.015_bib0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.bbr.2015.07.015_bib0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2012.02.087","article-title":"5-HT(1A) receptor and apoptosis contribute to interferon-alpha-induced depressive-like behavior in mice","volume":"514","author":"Ping","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.bbr.2015.07.015_bib0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2015.07.015_bib0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2015.07.015_bib0140","first-page":"909","article-title":"Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases","volume":"649","author":"Reyes Ocampo","year":"2014","journal-title":"Oxid. Med. Cell. longev."},{"issue":"10","key":"10.1016\/j.bbr.2015.07.015_bib0145","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","article-title":"Quinolinic acid is a potent lipid peroxidant in rat brain homogenates","volume":"16","author":"Rios","year":"1991","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.bbr.2015.07.015_bib0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0306-4530(00)00051-2","article-title":"Acute interferon-alpha administration modulates sucrose consumption in the rat","volume":"26","author":"Sammut","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2015.07.015_bib0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission","volume":"8","author":"Steiner","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.bbr.2015.07.015_bib0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.bbr.2015.07.015_bib0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neulet.2009.01.050","article-title":"Decreased immobility in swimming test by homologous interferon-alpha in mice accompanied with increased cerebral tryptophan level and serotonin turnover","volume":"452","author":"Wang","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.bbr.2015.07.015_bib0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpsychores.2006.09.007","article-title":"Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol","volume":"62","author":"Wichers","year":"2007","journal-title":"J. Psychosom. Res."},{"issue":"6","key":"10.1016\/j.bbr.2015.07.015_bib0175","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2015.07.015_bib0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-3565(24)35275-9","article-title":"Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice","volume":"292","author":"Yamano","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bbr.2015.07.015_bib0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.stemcr.2014.05.015","article-title":"Mechanisms for interferon-alpha-induced depression and neural stem cell dysfunction","volume":"3","author":"Zheng","year":"2014","journal-title":"Stem Cell Rep."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815300917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815300917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:09:54Z","timestamp":1748524194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432815300917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":37,"alternative-id":["S0166432815300917"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2015.07.015","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-alpha treatment induces depression-like behaviour accompanied by elevated hippocampal quinolinic acid levels in rats","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2015.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}